News

GVK BIO and Aragen Bioscience Sign Definitive Agreement to Acquire Aragen Bioscience, Inc.

The acquisition of Aragen Bioscience provides GVK BIO with world-class expertise in large molecule R&D services and a unique and extensive set of high-content biological services. Combined with GVK BIO’s established small molecule discovery and development capabilities, the acquisition of Aragen Bioscience uniquely positions GVK BIO as a leading provider of integrated R&D services across both large and small molecule platforms and provides a base for further expansion. <MORE

Events

BioProcessing Summit 2015

August 3-7
Booth # 407
Boston, MA

We are excited for this year’s BioProcessing Summit in Boston. Discover how Aragen Bioscience can transform the way you do research by visiting us at Booth 407 for a discussion with our team about our newest service offerings.